Academic
Publications
Successful retreatment with alitretinoin in patients with relapsed chronic hand eczema

Successful retreatment with alitretinoin in patients with relapsed chronic hand eczema,10.1111/j.1365-2133.2009.09572.x,British Journal of Dermatology

Successful retreatment with alitretinoin in patients with relapsed chronic hand eczema   (Citations: 10)
BibTex | RIS | RefWorks Download
Journal: British Journal of Dermatology - BRIT J DERMATOL , vol. 162, no. 2, pp. 420-426, 2010
Cumulative Annual
View Publication
The following links allow you to view full publications. These links are maintained by other sources not affiliated with Microsoft Academic Search.
    • ...The anti-inflammatory and immunomodulatory properties of alitretinoin induce high response rates with a favourable safety-profile over a long-term management of the treatment [12-14]...
    • ...The clinical data and the treatment protocol stem from two double-blind, randomised, placebo-controlled clinical studies (BACH) described by Ruzicka et al [12-14] and a Swiss dermatology opinion leader (Dr...
    • ...A hypothetical cohort of 1'000 patients was simulated with the same endpoints, treatments used, therapy duration, entry criteria and demographic characteristics as documented in these trials [12-14]...
    • ...The average duration of treatment for responding patients receiving alitretinoin or supportive care was 15.43 weeks or 18.12 weeks for the first cycle and 14.77 weeks or 17.66 weeks for the re-treatment phase, respectively[14]...
    • ...Blank et al. BMC Dermatology 2010, 10:4 http://www.biomedcentral.com/1471-5945/10/4 Page 5 of 9 mantle et al [14,26]...

    Patricia R Blanket al. Cost-effectiveness of oral alitretinoin in patients with severe chroni...

Sort by: